Concepedia

Kristoffer W. Balling

KW

5

Publications

448

Citations

5

H-Index

2010

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

Kristoffer W. Balling is an author at Novo Nordisk (Denmark) specializing in hematology, medicine, and clinical chemistry.

ORCID

Top concepts

Publications per year

2010–2019

5

Publications

5

Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model

Ida Hilden, Brian Lauritzen, Brit B. Sørensen et al. · Blood · 2012 · 147 citations

Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide

Jais Rose Bjelke, Lene Hansen, Lars C. Petersen et al. · Blood · 2011 · 136 citations · Full text

A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models

Henning R. Stennicke, Marianne Kjalke, Ditte M. Karpf et al. · Blood · 2013 · 114 citations · Full text

Functional characteristics of N8, a new recombinant FVIII

Marie Louise S. Christiansen, Kristoffer W. Balling, Egon Persson et al. · Haemophilia · 2010 · 41 citations · Full text

, , +18

Administration of recombinant FVIIa (rFVIIa) to concizumab‐dosed monkeys is safe, and concizumab does not affect the potency of rFVIIa in hemophilic rabbits

Brian Lauritzen, Janne Olling, Kristin L. Abel et al. · Journal of Thrombosis and Haemostasis · 2019 · 10 citations

Rows per page

1–5 of 5